Results 81 to 90 of about 11,766 (177)

Assessment of cardiovascular disease in immune thrombotic thrombocytopenic purpura. [PDF]

open access: yesRes Pract Thromb Haemost
Evangelidis P   +3 more
europepmc   +1 more source

Vaccine-induced thrombotic thrombocytopenic purpura

open access: yesJournal of Clinical and Scientific Research, 2022
Sudha Vidyasagar
doaj   +1 more source

In reply: epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany. [PDF]

open access: yesRes Pract Thromb Haemost
Scharenberg AY   +9 more
europepmc   +1 more source

Precision medicine in thrombotic thrombocytopenic purpura: a narrative review. [PDF]

open access: yesTher Adv Hematol
Al-Shibly R   +5 more
europepmc   +1 more source

NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura. [PDF]

open access: yesBlood Vessel Thromb Hemost
Buonomo SM   +4 more
europepmc   +1 more source

Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors. [PDF]

open access: yesRes Pract Thromb Haemost
Story CM   +3 more
europepmc   +1 more source

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]

open access: yesFront Pharmacol
Markovic U   +16 more
europepmc   +1 more source

Regarding "Challenges in diagnosing thrombotic thrombocytopenic purpura". [PDF]

open access: yesHematol Transfus Cell Ther
Martins de Oliveira Filho C, Carney BJ.
europepmc   +1 more source

Home - About - Disclaimer - Privacy